Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga



Insiderslab.com has issued insider trading reports for stock investing: J.C. Penney (NYSE:JCP), Gilead Sciences (NASDAQ:GILD), Chesapeake Energy (NYSE:CHK), Annaly Capital Management (NYSE:NLY), Endo Health Solutions (NASDAQ:ENDP), and Zynga (NASDAQ:ZNGA).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
J.C. Penney Company, Inc. (NYSE:JCP): By the end of last trading session, the shares of J.C. Penney (NYSE:JCP) rose US$0.52 (or 2.93%) to US$18.24 with 21.06 million shares exchanged hands, compared to daily average volume of 22.58 million. The trading price ranged between US$18.15 and US$19.03. The company shareholders experienced about 47% lost in the past 52 weeks. Insiderslab.com found company insiders sold his/her shares for about US$160.30 million in March. Investors may want to find out how J.C. Penney insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for JCP here.
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/JCP/JCPenney.pdf
 
Gilead Sciences, Inc. (NASDAQ:GILD): By the end of last trading session, Gilead Sciences (NASDAQ:GILD) shares earned US$1.59 (or 3.01%) to US$54.47 with about 14.49 million shares exchanged hands for the session, compared to its average volume of 12.88 million shares. The share reached the 52-week high of US$56.35 recently. The stock price rose more than 110% in the past year. Insiderslab.com found company CEO, John C. Martin, sold his shares at price of US$50.17 on May 1, which was part of about US$39.97 million selling in the past three months. Investors may want to find out how Gilead Sciences insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/GILD/GileadSciences.pdf
 
Chesapeake Energy Corporation (NYSE:CHK): By the end of last trading session, Chesapeake Energy (NYSE:CHK) up US$0.41 (or 2.03%) to US$20.56 with about 19.32 million shares exchanged hands for the session, compared to its average volume of 9.62 million shares. Insiderslab.com found company insiders sold his/her shares at price of US$22.00 – US$22.32 for about US$1.95 million. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Chesapeake Energy are starting to buy more company shares. See insider trade report for CHK here.
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/CHK/ChesapeakeEnergy.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Annaly Capital Management, Inc. (NYSE:NLY):
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/NLY/AnnalyCapitalManagement.pdf
 
Endo Health Solutions Inc (NASDAQ:ENDP):
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/ENDP/EndoHealthSolutions.pdf
 
Zynga Inc (NASDAQ:ZNGA):
 
Read Full Report: http://www.insiderslab.com/PR3/051413A/ZNGA/Zynga.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on May 14, 2013

 
More Insider News ...

Today's Notable Trades


OVERSEAS SHIPHOLDING GROUP INC (OSGIQ)
10% shareholder: Luxor Capital Group, LP

Acquired 100,000 Class A Warrants (Right to Buy) (Derivative security at conversion or exercise price: $0.010) on Oct 29, 2014. Indirect holding 618,876 shares/units after transaction. Class A Warrants (Right to Buy) expires on Aug 5, 39. Holdings increased 19.27%.
Filing date: Oct 31, 2014. Record updated at 22:01:51.
 
ADOBE SYSTEMS INC (ADBE)
Senior Officer (EVP, CFO & Asst. Secretary): GARRETT MARK

Acquired 34,000 Common Stock (Non-Derivative security at $34.160) on Oct 31, 2014. Direct holding 45,899 shares/units after transaction. Holdings increased 285.74%.
Filing date: Oct 31, 2014. Record updated at 22:01:50.
 
Karyopharm Therapeutics Inc. (KPTI)
Director: Mirza Mansoor Raza

Sold 3,500 Common Stock (Non-Derivative security at $40.046) on Oct 29, 2014. Direct holding 17,727 shares/units after transaction. Holdings decreased -16.49%.
Filing date: Oct 31, 2014. Record updated at 22:01:47.
 
CATHAY GENERAL BANCORP (CATY)
First-Class Insider (Vice Chairman): TANG ANTHONY M

Sold 200,000 Common Stock (Non-Derivative security at $25.680) on Oct 29, 2014. Indirect holding 1,524,497 shares/units after transaction. Holdings decreased -11.60%.
Filing date: Oct 31, 2014. Record updated at 22:01:45.
 
RESMED INC (RMD)
First-Class Insider (Chairman of the Board): FARRELL PETER C

Acquired 119,204 ResMed Common Stock (Non-Derivative security at $12.468) on Oct 29, 2014. Direct holding 400,468 shares/units after transaction. Holdings increased 42.38%.
Filing date: Oct 30, 2014. Record updated at 22:01:31.
 
NATUS MEDICAL INC (BABY)
Director: GUNST ROBERT A

Acquired 10,000 Common Stock, $0.001 par value per share (Non-Derivative security at $10.030) on Oct 30, 2014. Direct holding 60,750 shares/units after transaction. Holdings increased 19.70%.
Filing date: Oct 31, 2014. Record updated at 22:01:25.
 
Sientra, Inc. (SIEN)
10% shareholder: Abingworth LLP

Acquired 495,000 Common Stock (Non-Derivative security at $15.000) on Oct 29, 2014. Indirect holding 2,199,012 shares/units after transaction. Holdings increased 29.05%.
Filing date: Oct 31, 2014. Record updated at 22:01:22.
 
QUANTUMSPHERE, INC. (QSIM)
Director: PALMER JEFFERY WAYNE

Acquired 100,000 Common Stock (Non-Derivative security at $1.000) on Oct 31, 2014. Indirect holding 793,556 shares/units after transaction. Holdings increased 14.42%.
Filing date: Oct 31, 2014. Record updated at 22:01:21.
 
MACK CALI REALTY CORP (CLI)
Director: Litt Jonathan

Sold 187,400 Common Stock (Non-Derivative security at $18.518) on Oct 29, 2014. Indirect holding 290,000 shares/units after transaction. Holdings decreased -39.25%.
Filing date: Oct 31, 2014. Record updated at 22:01:16.
 
SANDISK CORP (SNDK)
Director: MARKS MICHAEL E

Acquired 6,250 Common Stock (Non-Derivative security at $46.430) on Oct 30, 2014. Direct holding 14,664 shares/units after transaction. Holdings increased 74.28%.
Filing date: Oct 31, 2014. Record updated at 22:01:14.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.